Linda Garland is a board-certified medical oncologist whose clinical interests include mesothelioma.
- Serves as director of the center’s Clinical Lung Cancer Program.
- Research interest in experimental therapeutics.
- Currently conducting research to identify molecular pathways through which new chemotherapy and gene-therapy agents can gain access to the inner workings of tumor cells so that their functions can be selectively disrupted (believes this will cause greater damage to tumor cells and less harm to neighboring normal cells).
- M.D. degree from University of Texas Health Science Center.